Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Another 2.4 million people in this country are chronically infected with hepatitis B, which is the leading cause of liver cancer globally. Hepatitis B is preventable, and hepatitis C is curable.

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

Individuals living with chronic hepatitis B will be affected by the cuts and closures as well, with reduced access to essential services for prevention, testing, and treatment, said Chari A.

The victim also undergoes HIV test; first report negative, woman shifted to Sir Sundar Lal Hospital where her condition is improving, says doctor VARANASI The 19-year-old victim, allegedly gang ...

A silent infection is fuelling a rise in liver cancer deaths around the country, prompting the federal Health Department to consider universal hepatitis B testing for people aged over 25.

The Health Promotion Administration (HPA) is considering expanding the eligibility for government-funded hepatitis B and C screening to include people aged 40 and older, and aiming to do that by July, ...

Our Phase 2 trial of hydronidone for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis showed that adding hydronidone to entecavir resulted in significant reversal of liver ...